CERo Therapeutics (CERO) announces its Board of Directors has appointed Chris Ehrlich as CEO. Previously he held the position of Interim CEO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERO:
- Cero Therapeutics files to sell 210M shares of common stock for holders
- 3 Penny Stocks to Watch Now, 11/19/24
- Cero Therapeutics receives FDA clearance of IND application for CER-1236
- 3 Penny Stocks to Watch Now, 11/14/24
- CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data